Inspired by the success of fluorinated corticosteroids in the 1950s and fluoroquinolones in the 1980s, fluorine-containing pharmaceuticals, which are also known as fluoro-pharmaceuticals, have been attracting attention for more than half of a century. Presently, about 20% of the commercial pharmaceuticals are fluoro-pharmaceuticals. In this mini-review, we analyze the prevalence of fluoro-pharmaceuticals in the market and categorize them into several groups based on the chemotype of the fluoro-functional groups, their therapeutic purpose, and the presence of heterocycles and/or chirality to highlight the structural motifs, patterns, and promising trends in fluorine-based drug design. Our database contains 340 fluoro-pharmaceuticals, from the first fluoro-pharmaceutical, Florinef, to the latest fluoro-pharmaceuticals registered in 2019 and drugs that have been withdrawn. The names and chemical structures of all the 340 fluorinated drugs discussed are provided in the Supporting Information.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240833 | PMC |
| http://dx.doi.org/10.1021/acsomega.0c00830 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fluorinated azoles as effective weapons in fight against methicillin-resistance staphylococcus aureus (MRSA) and its SAR studies.
Bioorg Chem
February 2024
DOS in Chemistry, Manasagangotri, University of Mysore, Mysuru 570006, India. Electronic address:
The rapid spread of Methicillin-resistant Staphylococcus aureus (MRSA) and its difficult-to-treat skin and filmsy diseases are making MRSA a threat to human life. The most dangerous feature is the fast emergence of MRSA resistance to all recognized antibiotics, including vancomycin. The creation of novel, effective, and non-toxic drug candidates to combat MRSA isolates is urgently required.
View Article and Find Full Text PDFA review: FDA-approved fluorine-containing small molecules from 2015 to 2022.
Eur J Med Chem
November 2023
Department of Medicinal Chemistry, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran. Electronic address:
Fluorine-containing small molecules have occupied a special position in drug discovery research. The successful clinical use of fluorinated corticosteroids in the 1950s and fluoroquinolones in the 1980s led to an ever-increasing number of approved fluorinated compounds over the last 50 years. They have shown various biological properties such as antitumor, antimicrobial, and anti-inflammatory activities.
View Article and Find Full Text PDFChemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016-2022).
Pharmaceuticals (Basel)
August 2023
School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4001, South Africa.
Article Synopsis
- - Fluorine's high electronegativity and small size enhance drug properties like potency, selectivity, and metabolic stability, making it a key focus in drug research for improving biological activity.
- - Selective fluorine substitution in drugs can boost pharmacokinetic features such as membrane permeation and binding ability to proteins, showing its significant role in drug development.
- - This review discusses FDA-approved fluorinated drugs from 2016 to 2022, highlighting various drug structures and the use of fluorine as a radiolabel in PET imaging.
Contribution of Organofluorine Compounds to Pharmaceuticals.
ACS Omega
May 2020
Department of Life Science and Applied Chemistry, Department of Nanopharmaceutical Sciences, Nagoya Institute of Technology, Gokiso, Showa-ku, Nagoya 466-5888, Japan.
Inspired by the success of fluorinated corticosteroids in the 1950s and fluoroquinolones in the 1980s, fluorine-containing pharmaceuticals, which are also known as fluoro-pharmaceuticals, have been attracting attention for more than half of a century. Presently, about 20% of the commercial pharmaceuticals are fluoro-pharmaceuticals. In this mini-review, we analyze the prevalence of fluoro-pharmaceuticals in the market and categorize them into several groups based on the chemotype of the fluoro-functional groups, their therapeutic purpose, and the presence of heterocycles and/or chirality to highlight the structural motifs, patterns, and promising trends in fluorine-based drug design.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!